ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Oral Versus Injectable Risperidone for Treating First-Episode Schizophrenia

This study is currently recruiting participants.
Study NCT00330551.   Last updated on January 4, 2008.   Information provided by National Institute of Mental Health (NIMH)
Please refer to this study by its ClinicalTrials.gov identifier: NCT00330551


Contacts
Contact: Rosemary Collier, MS     310-206-3142     rcollier@mednet.ucla.edu    
Contact: Luana Turner, PsyD     310-206-3142     luana@ucla.edu    

Locations
United States, California
Semel Institute for Neuroscience and Human Behavior at UCLA     Recruiting
      Los Angeles, California, United States, 90095
      Principal Investigator: Keith H. Nuechterlein, PhD            
      Sub-Investigator: Kenneth L. Subotnik, PhD            

Sponsors and Collaborators
National Institute of Mental Health (NIMH)

Investigators
Principal Investigator:     Keith H. Nuechterlein, PhD     University of California, Los Angeles, Department of Psychiatry and Biobehavioral Sciences    


U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act
U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services



Links to all studies - primarily for crawlers